X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (521) 521
Newsletter (36) 36
Publication (25) 25
Newspaper Article (9) 9
Book Review (6) 6
Book Chapter (2) 2
Conference Proceeding (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
indacaterol (510) 510
index medicus (295) 295
humans (265) 265
respiratory system (237) 237
copd (225) 225
pulmonary disease, chronic obstructive - drug therapy (214) 214
lung diseases, obstructive (206) 206
tiotropium (197) 197
chronic obstructive pulmonary disease (187) 187
obstructive pulmonary-disease (183) 183
male (149) 149
female (143) 143
treatment outcome (130) 130
pulmonary disease, chronic obstructive - physiopathology (129) 129
middle aged (124) 124
efficacy (123) 123
bronchodilator agents - administration & dosage (118) 118
drug therapy (118) 118
aged (117) 117
salmeterol (110) 110
asthma (105) 105
safety (101) 101
administration, inhalation (100) 100
bronchodilator agents - therapeutic use (99) 99
quinolones - administration & dosage (98) 98
indans - administration & dosage (97) 97
pharmacology & pharmacy (93) 93
formoterol (89) 89
care and treatment (83) 83
dosage and administration (80) 80
double-blind (76) 76
quinolones - therapeutic use (75) 75
indans - therapeutic use (74) 74
diseases of the respiratory system (72) 72
bronchodilator agents - adverse effects (71) 71
research (71) 71
adrenergic beta-2 receptor agonists - administration & dosage (70) 70
double-blind method (68) 68
indans - adverse effects (66) 66
quinolones - adverse effects (66) 66
drug therapy, combination (65) 65
glycopyrronium (65) 65
pulmonary disease, chronic obstructive - diagnosis (63) 63
once-daily indacaterol (62) 62
bronchodilators (61) 61
severity of illness index (60) 60
analysis (58) 58
international journal of chronic obstructive pulmonary disease (57) 57
lung - physiopathology (56) 56
forced expiratory volume (55) 55
bronchodilator (54) 54
exacerbations (54) 54
lung - drug effects (53) 53
adrenergic beta-2 receptor agonists - therapeutic use (51) 51
dyspnea (51) 51
pulmonary/respiratory (51) 51
time factors (51) 51
adrenergic beta-2 receptor agonists - adverse effects (48) 48
drug administration schedule (48) 48
original research (48) 48
medical research (47) 47
adult (46) 46
drug combinations (46) 46
pulmonary and respiratory medicine (46) 46
quality of life (46) 46
medicine, experimental (44) 44
respiratory tract diseases (44) 44
forced expiratory volume - drug effects (43) 43
dose-response relationship, drug (42) 42
lung-function (42) 42
muscarinic antagonists - administration & dosage (41) 41
placebo (38) 38
qva149 (38) 38
muscarinic antagonists - therapeutic use (37) 37
randomized controlled trials as topic (37) 37
glycopyrrolate - administration & dosage (36) 36
pharmaceutical industry (36) 36
tiotropium bromide (36) 36
clinical trials (35) 35
cross-over studies (35) 35
cardiac & cardiovascular systems (34) 34
respiratory agents (34) 34
bronchodilation (33) 33
lung hyperinflation (33) 33
pharmacological characterization (33) 33
review (33) 33
beta-agonist (32) 32
combination (32) 32
glycopyrrolate - adverse effects (31) 31
inhaled corticosteroids (31) 31
lung diseases (31) 31
patient outcomes (31) 31
complications and side effects (30) 30
medicine, general & internal (30) 30
muscarinic antagonists - adverse effects (30) 30
twice-daily salmeterol (30) 30
bronchodilator agents (29) 29
corticosteroids (29) 29
indacaterol/glycopyrronium (29) 29
studies (29) 29
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (538) 538
German (5) 5
Korean (4) 4
Russian (4) 4
Spanish (4) 4
Czech (3) 3
Polish (3) 3
French (2) 2
Portuguese (2) 2
Italian (1) 1
Japanese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Medicinal Chemistry, ISSN 0223-5234, 05/2018, Volume 152, p. 424
A new series of [beta].sub.2-adrenoceptor agonists bearing the 2-amino-2-phenylethanol scaffold was synthesized. Evaluation of the compounds using cell assays... 
Analysis | Indacaterol
Journal Article
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 06/2019, Volume 27, Issue 12, p. 2306
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 05/2018, Volume 152, pp. 424 - 435
A new series of β -adrenoceptor agonists bearing the 2-amino-2-phenylethanol scaffold was synthesized. Evaluation of the compounds using cell assays and an in... 
Bronchodilators | Indacaterol | Adrenoceptor agonists | Trantinterol
Journal Article
Chest, ISSN 0012-3692, 05/2018, Volume 153, Issue 5, pp. 1116 - 1124
In COPD, functional status is improved by pulmonary rehabilitation (PR) but requires specific facilities. Tai Chi, which combines psychological treatment and... 
Tai Chi | pulmonary rehabilitation | indacaterol | COPD
Journal Article
COPD: Journal of Chronic Obstructive Pulmonary Disease, ISSN 1541-2555, 03/2019, Volume 16, Issue 2, pp. 133 - 139
Bronchodilator reversibility occurs in patients with COPD. Pooled analysis of two 12-week, placebo-controlled randomised studies (FLIGHT1 [NCT01727141];... 
reversibility | indacaterol/glycopyrrolate | Bronchodilator | COPD | glycopyrrolate | indacaterol | RESPIRATORY SYSTEM | BRONCHODILATOR RESPONSIVENESS
Journal Article
Respiration, ISSN 0025-7931, 04/2018, Volume 95, Issue Suppl 1, pp. 6 - 10
We present the case of a 77-year-old man diagnosed with chronic obstructive pulmonary disease (COPD) stage D with emphysema phenotype and treated with triple... 
Case Report | Chronic obstructive pulmonary disease | GOLD stage | Ventilatory response to exercise | Indacaterol/ glycopyrronium | MILD | Indacaterol/glycopyrronium | DIAGNOSIS | MANAGEMENT | RESPIRATORY SYSTEM | CONSTRAINTS | EXERCISE | COPD | Tiotropium | Medical research | Lung diseases, Obstructive | Medicine, Experimental | Development and progression | Indacaterol | Fluticasone
Journal Article
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 06/2019, Volume 27, Issue 12, pp. 2306 - 2314
A series of novel β -adrenoceptor agonists with a 5-(2-amino-1-hydroxyethyl)-8-hydroxyquinolin-2(1 )-one moiety was designed, synthesized and evaluated for... 
Indacaterol | β2-Adrenoceptor agonist | Trantinterol | Salmeterol | Asthma | COPD | Adrenoceptor agonist
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 01/2014, Volume 15, Issue 1, pp. 139 - 142
Introduction: In COPD, the long-acting bronchodilators are not always able to provide an appropriate bronchodilator effect in terms of amplitude and duration... 
glycopyrronium | indacaterol | bronchodilator | COPD
Journal Article
CHEST, ISSN 0012-3692, 05/2014, Volume 145, Issue 5, pp. 981 - 991
Background: Combination long-acting bronchodilator therapy may be more effective than long acting bronchodilator monotherapy in COPD. Our objectives were to... 
INDACATEROL | FORMOTEROL | OBSTRUCTIVE PULMONARY-DISEASE | PLACEBO | EFFICACY | RESPIRATORY SYSTEM | DOUBLE-BLIND | LUNG-FUNCTION | TIOTROPIUM | ANTICHOLINERGICS | COMBINATION | CRITICAL CARE MEDICINE
Journal Article
ARCHIVOS DE BRONCONEUMOLOGIA, ISSN 0300-2896, 04/2019, Volume 55, Issue 4, pp. 185 - 186
Journal Article
RESPIROLOGY, ISSN 1323-7799, 02/2012, Volume 17, Issue 2, pp. 379 - 389
Background and objective: The efficacy and safety of indacaterol, a novel inhaled once daily ultra long-acting beta(2)-agonist was evaluated in COPD patients... 
BETA-AGONIST | indacaterol | RESPIRATORY SYSTEM | safety | ONCE-DAILY INDACATEROL | TIOTROPIUM | PREVALENCE | Asian population | efficacy | bronchodilator | COPD
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 05/2018, Volume 152, pp. 424 - 435
A new series of β -adrenoceptor agonists bearing the 2-amino-2-phenylethanol scaffold was synthesized. Evaluation of the compounds using cell assays and an... 
β2-Adrenoceptor agonists | Bronchodilators | Indacaterol | Trantinterol
Journal Article
Molecules and Cells, ISSN 1016-8478, 2014, Volume 37, Issue 8, pp. 585 - 591
Journal Article
THORAX, ISSN 0040-6376, 06/2015, Volume 70, Issue 6, pp. 519 - 527
Background The optimal use of various therapeutic combinations for moderate/severe chronic obstructive pulmonary disease (COPD) is unclear. The GLISTEN trial... 
PROPIONATE | INDACATEROL | MODERATE | FORMOTEROL | OBSTRUCTIVE PULMONARY-DISEASE | EFFICACY | RESPIRATORY SYSTEM | COPD Pharmacology | TIOTROPIUM | FLUTICASONE PROPIONATE/SALMETEROL | COMBINATION | SALMETEROL
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.